Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Melco International ( (HK:0200) ) has provided an update.
Melco International’s subsidiary, SCRS, has entered into an agreement with iRad to operate a private hospital specializing in imaging and diagnostic services at the Studio City integrated resort. This agreement, effective from January 2025, is set for an initial period until November 2034, with options for renewal. The transaction is classified as a continuing connected transaction under Hong Kong’s Listing Rules, requiring reporting and annual review but exempt from independent shareholder approval.
The most recent analyst rating on (HK:0200) stock is a Hold with a HK$6.70 price target. To see the full list of analyst forecasts on Melco International stock, see the HK:0200 Stock Forecast page.
More about Melco International
Melco International Development Limited is a company incorporated in Hong Kong, operating in the integrated resort industry. It focuses on providing entertainment and hospitality services, with a market emphasis on luxury resorts and gaming establishments.
Average Trading Volume: 18,246,168
Technical Sentiment Signal: Hold
Current Market Cap: HK$12.28B
See more insights into 0200 stock on TipRanks’ Stock Analysis page.